Sinopharm Tech Holdings Limited clarified that its second FY-2026 annual results announcement, released at 22:34 on 24 September 2026, differs from the first version issued 32 minutes earlier solely by the inclusion of an additional cover page. No other amendments or updates were made to the financial statements or accompanying disclosures.

The clarification, dated 29 September 2026, was signed by Executive Director Ms. Kwok Shuk Yi on behalf of the Board. The Board currently comprises two executive directors—Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi—and four independent non-executive directors: Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming.

The company reiterated that the information in the original filing remains accurate and complete to the best of the directors’ knowledge. Both announcements will remain available on the Hong Kong Stock Exchange’s website for at least seven days and can also be accessed via the company’s website.